KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis

We investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restric...

Full description

Bibliographic Details
Main Authors: Agnieszka Paradowska-Gorycka, Barbara Stypinska, Andrzej Pawlik, Damian Malinowski, Katarzyna Romanowska-Prochnicka, Malgorzata Manczak, Marzena Olesinska
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Biomolecules
Subjects:
KDR
Online Access:https://www.mdpi.com/2218-273X/9/8/355
id doaj-a7511ae58f204f4f976e1e5c55ef373d
record_format Article
spelling doaj-a7511ae58f204f4f976e1e5c55ef373d2020-11-24T21:25:12ZengMDPI AGBiomolecules2218-273X2019-08-019835510.3390/biom9080355biom9080355KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid ArthritisAgnieszka Paradowska-Gorycka0Barbara Stypinska1Andrzej Pawlik2Damian Malinowski3Katarzyna Romanowska-Prochnicka4Malgorzata Manczak5Marzena Olesinska6Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, PolandDepartment of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Spartańska 1, 02-637 Warsaw, PolandDepartment of Physiology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Pharmacology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Gerontology and Health Promotion, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandDepartment of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, PolandWe investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method and for rs2305948 and rs2071559 KDR single nucleotide polymorphisms (SNPs) by TaqMan SNP genotyping assay. KDR serum levels were determined by enzyme-linked immunosorbent assay (ELISA). The rs1870377 KDR variant has shown association with RA under the codominant (<i>p</i> = 0.02, OR = 1.76, 95% CI = 1.09&#8722;2.85) and recessive models (<i>p</i> = 0.019, OR = 1.53, 95% CI = 1.07&#8722;2.20). KDR rs2305948 was associated with RA under the dominant model (<i>p</i> = 0.005, OR = 1.38, 95% CI = 1.10&#8722;1.73). Under the codominant model, the frequency of the rs2071559 TC and GG genotypes were lower in RA patients than in controls (<i>p</i> &lt; 0.001, OR = 0.51, 95% CI = 0.37&#8722;0.69, and <i>p</i> = 0.002, OR = 0.57, 95% CI = 0.39&#8722;0.81). KDR rs2071559 T and rs2305948 A alleles were associated with RA (<i>p</i> = 0.001, OR = 0.60, 95% CI = 0.45&#8722;0.81 and <i>p</i> = 0.008, OR = 1.71, CI = 1.15&#8722;2.54). KDR rs2305948SNP was associated with Disease Activity Score (DAS)-28 score (<i>p</i> &lt; 0.001), Visual Analog Scale (VAS) score (<i>p</i> &lt; 0.001), number of swollen joints (<i>p</i> &lt; 0.001), mean value of CRP (<i>p</i> &lt; 0.001). A higher KDR serum level was found in RA patients than in HC (8018 pg/mL versus 7381 pg/mL, <i>p</i> = 0.002). Present results shed light on the role of KDR genetic variants in the severity of RA.https://www.mdpi.com/2218-273X/9/8/355angiogenesisinflammationgene polymorphismsKDRrheumatoid arthritisprotein level
collection DOAJ
language English
format Article
sources DOAJ
author Agnieszka Paradowska-Gorycka
Barbara Stypinska
Andrzej Pawlik
Damian Malinowski
Katarzyna Romanowska-Prochnicka
Malgorzata Manczak
Marzena Olesinska
spellingShingle Agnieszka Paradowska-Gorycka
Barbara Stypinska
Andrzej Pawlik
Damian Malinowski
Katarzyna Romanowska-Prochnicka
Malgorzata Manczak
Marzena Olesinska
KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
Biomolecules
angiogenesis
inflammation
gene polymorphisms
KDR
rheumatoid arthritis
protein level
author_facet Agnieszka Paradowska-Gorycka
Barbara Stypinska
Andrzej Pawlik
Damian Malinowski
Katarzyna Romanowska-Prochnicka
Malgorzata Manczak
Marzena Olesinska
author_sort Agnieszka Paradowska-Gorycka
title KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
title_short KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
title_full KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
title_fullStr KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
title_full_unstemmed KDR (VEGFR2) Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
title_sort kdr (vegfr2) genetic variants and serum levels in patients with rheumatoid arthritis
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2019-08-01
description We investigated kinase insert domain-containing receptor (KDR) polymorphisms and protein levels in relation to susceptibility to and severity of Rheumatoid Arthritis (RA). 641 RA patients and 340 controls (HC) were examined for the rs1870377 KDR variant by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method and for rs2305948 and rs2071559 KDR single nucleotide polymorphisms (SNPs) by TaqMan SNP genotyping assay. KDR serum levels were determined by enzyme-linked immunosorbent assay (ELISA). The rs1870377 KDR variant has shown association with RA under the codominant (<i>p</i> = 0.02, OR = 1.76, 95% CI = 1.09&#8722;2.85) and recessive models (<i>p</i> = 0.019, OR = 1.53, 95% CI = 1.07&#8722;2.20). KDR rs2305948 was associated with RA under the dominant model (<i>p</i> = 0.005, OR = 1.38, 95% CI = 1.10&#8722;1.73). Under the codominant model, the frequency of the rs2071559 TC and GG genotypes were lower in RA patients than in controls (<i>p</i> &lt; 0.001, OR = 0.51, 95% CI = 0.37&#8722;0.69, and <i>p</i> = 0.002, OR = 0.57, 95% CI = 0.39&#8722;0.81). KDR rs2071559 T and rs2305948 A alleles were associated with RA (<i>p</i> = 0.001, OR = 0.60, 95% CI = 0.45&#8722;0.81 and <i>p</i> = 0.008, OR = 1.71, CI = 1.15&#8722;2.54). KDR rs2305948SNP was associated with Disease Activity Score (DAS)-28 score (<i>p</i> &lt; 0.001), Visual Analog Scale (VAS) score (<i>p</i> &lt; 0.001), number of swollen joints (<i>p</i> &lt; 0.001), mean value of CRP (<i>p</i> &lt; 0.001). A higher KDR serum level was found in RA patients than in HC (8018 pg/mL versus 7381 pg/mL, <i>p</i> = 0.002). Present results shed light on the role of KDR genetic variants in the severity of RA.
topic angiogenesis
inflammation
gene polymorphisms
KDR
rheumatoid arthritis
protein level
url https://www.mdpi.com/2218-273X/9/8/355
work_keys_str_mv AT agnieszkaparadowskagorycka kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT barbarastypinska kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT andrzejpawlik kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT damianmalinowski kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT katarzynaromanowskaprochnicka kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT malgorzatamanczak kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
AT marzenaolesinska kdrvegfr2geneticvariantsandserumlevelsinpatientswithrheumatoidarthritis
_version_ 1725984160926924800